An “Alternative” Alternative Investment Manager founded in 2011 by Dr. Martin Coward, dormouse uses rigourous scientific methodologies to test and develop rule-based strategies for investing in global financial markets.

Dr. Coward, an internationally recognised pioneer of European quantitative hedge funds, co-founded IKOS in 1992 where, until his resignation in December 2009, he was Chief Investment Officer and Chairman. IKOS' unique trading strategies developed and directed by Martin enabled it to become one of the most successful hedge funds in the world, with peak assets of $3.5bn.

dormouse is a scientific research company focused on financial markets, as opposed to a financial company which utilises science. This is a key distinction and we believe this is essential in defining the philosophical difference in the way we operate relative to our competitors.

dormouse Limited is a Category 2 Licensed Investment firm regulated by the Malta Financial Services Authority (“MFSA”). dormouse is also registered with the United States Commodities and Futures Trading Commission (“CFTC”) as a Commodity Trading Advisor (“CTA”) and a Commodity Pool Operator (“CPO”) and is a member of the National Futures Association (“NFA”).